Navigation Links
Detke Joins MedAvante as Chief Medical Officer
Date:3/12/2009

Former Eli Lilly executive Michael J. Detke, MD, PhD, is frequent presenter on the causes of failed clinical studies for central nervous system (CNS) therapeutics and methods for improvement

HAMILTON, N.J., March 12 /PRNewswire/ -- MedAvante, Inc. the leader in centralized psychiatric patient evaluation, announced today that Michael Detke, MD, PhD, has joined the company as Chief Medical Officer and Director of the MedAvante Research Institute. Dr. Detke comes to MedAvante from Eli Lilly, Inc., in Indianapolis, Indiana, where he was Executive Director and head of early phase development of CNS therapeutics.

"We are honored to have Michael join our team," says Paul Gilbert, Chief Executive Officer of MedAvante. "At Lilly, Mike led early phase development of one of the industry's deepest and strongest pipelines of CNS products. His earlier work on Cymbalta(R) and Prozac(R) proves that he is a top-caliber scientist dedicated to developing CNS therapeutics. At MedAvante, Mike will apply his leadership abilities, scientific expertise, and commitment to quality assurance to help us deliver our leading-edge methodology for removing sources of bias and variability, increasing signal detection, and reducing the high rate of failed CNS trials."

Dr. Detke says, "MedAvante holds great promise for ensuring the future success of CNS therapeutics. For decades and now acutely, our industry has struggled with the problems of rater bias and an inability to separate placebo response from active-drug response. MedAvante offers a potential powerful solution for these problems. Our methodology to substantially increase the efficiency of clinical studies can help bring new treatments to market for patients suffering from debilitating CNS diseases. Furthermore, it can help to elucidate efficacy further, to help patients and doctors understand, for example, the relative efficacy of different drugs for a disorder, or different doses
'/>"/>

SOURCE MedAvante, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jocelyn Frederick Joins Tsoi/Kobus & Associates as Principal
2. Michael J. Fox Foundation Joins Effort to Recruit 10,000 People With Parkinsons Disease to New Web-Based PD Research Community
3. Veteran Rehab Specialist, James Conwell, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
4. KevinMD.com Joins the HCPLive.com Network
5. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
6. Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio
7. Veteran Rehab Specialist, Donna Cole, Joins Fast-Growing Alliance Seating & Mobility in California
8. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
9. Wound Management Technologies Joins IMCO Vendor Network to Expand Sales Nationwide
10. Michael Forte Joins CONNEXION Healthcare as Chief Operations Officer
11. Julie Gallagher Joins Akerman Senterfitts Healthcare Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
(Date:4/17/2014)... Council scientists and their partners have found that their ... the transmission of multiple sexually transmitted infections (STIs) in ... simplex virus 2 (HSV-2), and human papillomavirus (HPV). The ... gel is effective against multiple strains of HIV, and ... all three viruses of at least eight hours prior ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... released by glioblastoma cells, can be detected, study shows ... stumbled across a novel mechanism by which brain tumors ... The findings expose a fundamental biological process of which ... be exploited to combat glioblastoma, experts said. But just ...
... nation,s largest and fastest growing database marketing agencies, announced that it ... private, not-for-profit contributor to arthritis research in the world. , ... ... www.merkleinc.com ), one of the nation,s largest and fastest growing database ...
... new website dedicated to tracking the business of robotics. , ... Santa ... is a new website dedicated to tracking the business of robotics. ... this growth industry:, , , , ,   • Service Robots for Governmental and ...
... A new study published in the New England Journal of Medicine ... the detection of heart disease and stroke risk. Life Line ... screenings. , ... Cleveland, OH (PRWeb) November 17, 2008 ...
... Researchers report promising results for the viability of ... technique that may enhance the differential diagnosis of ... skin in vivo. Recently published in "Lasers ... peer-reviewed professional journal of the American Society for ...
... adding the IQAirpurifier to their extensive health product line. For ... ($800 value) with the purchase of one of their Luxury Infrared ... ... 17, 2008 -- EvolutionHealth.com is adding air purifiers to their already ...
Cached Medicine News:Health News:Finding Points to Possible Blood Test for Brain Tumors 2Health News:Finding Points to Possible Blood Test for Brain Tumors 3Health News:Finding Points to Possible Blood Test for Brain Tumors 4Health News:Arthritis Foundation Renews Comprehensive Marketing Contract with Merkle 2Health News:Arthritis Foundation Renews Comprehensive Marketing Contract with Merkle 3Health News:New Website Launched, The Robot Report, Tracking The Business of Robotics 2Health News:New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke 2Health News:Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue 2Health News:Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue 3Health News:EvolutionHealth.com Adds Air Cleansing Purifier to Their Must-Have Products for Health 2Health News:EvolutionHealth.com Adds Air Cleansing Purifier to Their Must-Have Products for Health 3
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Frontage Laboratories, Inc., a ... US and China, and Spaulding Clinical Research, LLC, a ... Medical Device Manufacturer have entered into a strategic partnership ... footprint by combining Frontage,s presence in China and its ...
... SPRING, Md., Sept. 12, 2011 Today, the U.S. ... office responsible for reviewing all drug and biologic applications ... Research,s (CDER) Office of Oncology Drug Products has been ... Products (OHOP). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) ...
Cached Medicine Technology:Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 2Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 3FDA Announces Changes in Drug Center's Oncology Office 2FDA Announces Changes in Drug Center's Oncology Office 3
Adhesive tape sheets for sealing multiwell plates and blocks;...
Microwell Plate Accessories...
DMSO-resistant microplate sealing film...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Medicine Products: